MARAGANORE JOHN
SEC Form 4 insider trading activity
MARAGANORE JOHN has filed 4 SEC Form 4 filings (6 transaction rows) across 4 companies, including RAPP, CTY, TAK, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.
On the most recent filing, MARAGANORE JOHN is listed as Director at Rapport Therapeutics, Inc. Inside the rolling window, MARAGANORE JOHN reported 1 open-market purchase totaling $249K in RAPP and no open-market sales.
Companies traded
Other insiders at RAPP
Insider Buying
$249K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
4
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MARAGANORE JOHN made?
MARAGANORE JOHN has filed 4 SEC Form 4 filings (6 transaction rows) across 4 companies, including RAPP, CTY, TAK since 2026.
Which companies does MARAGANORE JOHN trade?
MARAGANORE JOHN has filed SEC Form 4 disclosures for 4 companies, including RAPP, CTY, TAK.
When was MARAGANORE JOHN's most recent SEC Form 4 filing?
MARAGANORE JOHN's most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.
What is MARAGANORE JOHN's total buy and sell value in the current window?
Inside the rolling retention window, MARAGANORE JOHN bought $249K and sold $0 based on SEC Form 4 filings.
What was MARAGANORE JOHN's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 9,411 RAPP shares on 2026-10-22, worth $249K, per SEC Form 4 filings.